Bristol Myers Squibb gets USFDA accelerated nod for Breyanzi as CAR T Cell Therapy for adults with relapsed or refractory chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Susmita Roy15 March 2024 12:32 PM ISTPrinceton: Bristol Myers Squibb has announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval of...
Merck announces Phase 3 trial initiations for 4 investigational candidates from its hematology, oncology pipeline Ruchika Sharma6 Jan 2024 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of pivotal Phase 3 trials for four of its...
Eli Lilly secures USFDA nod for leukemia treatment Jaypirca Ruchika Sharma2 Dec 2023 1:30 PM ISTThis is the second FDA-approved indication for Jaypirca following the January 2023 Accelerated Approval for the treatment of adult patients with...
Apixaban fails to check VTE among children with lymphocytic leukemia Niveditha Subramani22 Nov 2023 3:00 AM ISTAcute lymphocytic leukemia is the most common type of cancer in children, and treatments result in a good chance for a cure. However complications are...
Chronic lymphocytic leukemia- A treatable cancer Dr Meet Kumar21 Oct 2021 2:26 PM ISTChronic lymphocytic leukemia (CLL) is a type of cancerof the blood and bone marrow in which the bone marrow makes more lymphocytes than required....
